Hyperacute toxicity with combination ipilimumab and anti-PD1 immunotherapy
Helen Clare Dearden, Lewis Au, Daniel Wang, Lisa Zimmer, Zeynep Eroglu, Jessica L. Smith, Marcello Cuvietto, Chloe Khoo, Victoria Atkinson, Serigne Lo, Georgina V. Long, Shahneen Sandhu, Paolo A. Ascierto, Matteo S. Carlino, Douglas B. Johnson, James Larkin, Alexander M. Menzies
Topics & Concepts
MedicineIpilimumabImmunosuppressionToxicityInternal medicineNivolumabGastroenterologyPneumonitisRashImmunotherapyCancerLungCancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and ManagementMelanoma and MAPK Pathways